ZVRA

Zevra Therapeutics, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$11.16

Price (1 Year)

$13.98 $8.31

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0 / %30
Non-compliant assets / Total market cap %34.1 / %30
Non-compliant revenue / Total income %5.7 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform.

Website

Analysis (Turkish): ZVRA Hissesi Caiz mi, Helal mi? Zevra Therapeutics, Inc. Katılım Analizi